Mark Culhane - 01 Oct 2025 Form 4 Insider Report for Genasys Inc. (GNSS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Oct 2025, 16:09:20 UTC
Prior SEC filing
19 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cassandra Monteon as attorney-in-fact for Mark Culhane

Key filing fact

Mark Culhane filed Form 4 for Genasys Inc. (GNSS) on 03 Oct 2025.

Key facts

  • This page summarizes Mark Culhane's Form 4 filing for Genasys Inc. (GNSS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Oct 2025, 16:09.

Change

  • Previous filing in this sequence was filed on 19 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001407712 Primary reporting owner

Culhane Mark

Relationship
Director
Address
16262 WEST BERNARDO DRIVE, SAN DIEGO
Signature
/s/ Cassandra Monteon as attorney-in-fact for Mark Culhane
Signature date
03 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GNSS transaction

Common Stock

Award

Transaction value
$0
Shares
+6,411
Change %
+5.9%
Price
$0.000000
Shares after
114,547
Date
01 Oct 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of common stock granted to the reporting person in lieu of accrued cash retainer for the third and fourth quarters of fiscal year 2025. The number of shares was determined based on the cash value of the accrued retainer divided by the closing price of the Company's common stock on the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .